Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evolent Health

9.86
+0.02000.20%
Post-market: 9.860.00000.00%17:07 EDT
Volume:1.60M
Turnover:15.76M
Market Cap:1.13B
PE:-12.10
High:10.09
Open:10.08
Low:9.72
Close:9.84
Loading ...

Evolent Health Price Target Maintained With a $15.00/Share by Needham

Dow Jones
·
21 Feb

Evolent Health price target lowered to $16 from $17 at Piper Sandler

TIPRANKS
·
21 Feb

Analysts Conflicted on These Healthcare Names: Glaukos (GKOS), Danaher (DHR) and Evolent Health (EVH)

TIPRANKS
·
21 Feb

KeyBanc Sticks to Their Buy Rating for Evolent Health (EVH)

TIPRANKS
·
21 Feb

Evolent Health Inc (EVH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Oncology ...

GuruFocus.com
·
21 Feb

Evolent Health Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
21 Feb

Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For

StockStory
·
19 Feb

Evolent Health (NYSE:EVH) Is Doing The Right Things To Multiply Its Share Price

Simply Wall St.
·
19 Feb

Evolent Health (EVH) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Zacks
·
17 Feb

Earnings Preview: Evolent Health (EVH) Q4 Earnings Expected to Decline

Zacks
·
13 Feb

Evolent Health Names Rick Jelinek Board Chair, Succeeding Cheryl Scott

MT Newswires Live
·
04 Feb

BRIEF-Evolent Health Announces Changes To Board Of Directors

Reuters
·
04 Feb

Evolent Health Announces Changes to Board of Directors

THOMSON REUTERS
·
04 Feb

Evolent Health Inc - Rick Jelinek to Be Named Chair of Evolent Board

THOMSON REUTERS
·
04 Feb

Evolent Health Inc - Rick Jelinek to Succeed Cheryl Scott as Board Chair

THOMSON REUTERS
·
04 Feb

Evolent Health Announces Changes to Board of Directors

PR Newswire
·
04 Feb

New Strong Sell Stocks for January 30th

Zacks
·
30 Jan

Evolent Health price target lowered to $14 from $36 at TD Cowen

TIPRANKS
·
29 Jan

Evolent Health Inc : TD Cowen Cuts Target Price to $14 From $36

THOMSON REUTERS
·
29 Jan

Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025

PR Newswire
·
28 Jan